Skip to content
Trial Eligibility
Menu

SeizEAR Safety Study

NCT07088835

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Determine the safety and feasibility of an in-ear device to measure seizures or suspected seizures compared to the standard scalp-based electroencephalogram (EEG). The study team anticipates enrolling five healthy participants through meeting announcements and a research email list serv in the Neurology Dept. Based on the appropriate positive initial test of healthy individuals, test the in-ear device on 10 participants with seizures or suspected seizures scheduled for a clinical scalp EEG test.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Epilepsy

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
September 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Icahn School of Medicine at Mount Sinai · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.